Consenso mexicano CAMELICE/PPE/INNN sobre el uso actual de valproato en pacientes con epilepsia.
- Published in:
- Archivos de Neurociencias, 2025, v. 30, n. 2, p. 79, doi. 10.24875/ANC.25000003
- By:
- Publication type:
- Article
Works about DRUG therapy for psychoses
Results: 805
1
2
Cardiological Side Effects of Antipsychotic Agents.
- Published in:
- International Medical Journal, 2025, v. 32, n. 2, p. 69
- By:
- Publication type:
- Article
3
Severe cerebral venous thrombosis initially presenting as puerperium psychiatric and behavioral symptoms: one case report.
- Published in:
- Chinese Journal of Contemporary Neurology & Neurosurgery, 2025, v. 25, n. 6, p. 509, doi. 10.3969/j.issn.1672-6731.2025.06.009
- By:
- Publication type:
- Article
4
Psychosis in acute methamphetamine intoxication is usually self‐limiting and can be managed in the emergency department: A retrospective series.
- Published in:
- Emergency Medicine Australasia, 2024, v. 36, n. 1, p. 24, doi. 10.1111/1742-6723.14287
- By:
- Publication type:
- Article
5
Travma Sonrası Stres Bozukluğu ve Farmakoterapisi.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S94
- By:
- Publication type:
- Article
6
Sertindole-lnduced Hypomania: A Case Report.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2008, v. 18, n. 4, p. 296
- By:
- Publication type:
- Article
7
Antipsikotikler, Antidepresanlar: Meta-Analiz Güvenirliği.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2008, v. 18, n. 4, p. 245
- By:
- Publication type:
- Article
8
Yeni Kuşak Antipsikotiklerin Metabolik Yan Etkileri.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2004, v. 14, n. 3, p. 168
- By:
- Publication type:
- Article
9
Greater anticholinergic burden associated with poorer cognition in patients with psychosis.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 7, p. 6, doi. 10.1002/pu.31325
- Publication type:
- Article
10
Adults using clozapine have lower relapse rate, more adverse events.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 1, p. 6, doi. 10.1002/pu.31255
- Publication type:
- Article
11
Switch from antipsychotic polypharmacy to monotherapy reduces side effects.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 1, p. 1, doi. 10.1002/pu.31250
- Publication type:
- Article
12
Antipsychotic polypharmacy more effective in patients with greater severity.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 12, p. 8, doi. 10.1002/pu.31247
- Publication type:
- Article
13
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 11, p. 9, doi. 10.1002/pu.31234
- Publication type:
- Article
14
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 9, p. 9, doi. 10.1002/pu.31209
- Publication type:
- Article
15
ADHD drugs in patients with psychosis do not increase risk of psychiatric events.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 7, p. 8, doi. 10.1002/pu.31184
- Publication type:
- Article
16
Review finds limited benefit from cannabinoids for PTSD.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 7, p. 6, doi. 10.1002/pu.31181
- Publication type:
- Article
17
More pandemic reverberations: Focus on stimulants.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 7, p. 7, doi. 10.1002/pu.31180
- By:
- Publication type:
- Article
18
Managing antipsychotic intolerance via genetics.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 7, p. 2, doi. 10.1002/pu.31177
- By:
- Publication type:
- Article
19
Pharmacological treatments for psychotic depression.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 6, p. 2, doi. 10.1002/pu.31164
- By:
- Publication type:
- Article
20
Review finds VMAT‐2 inhibitors promising for treatment of psychosis.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 5, p. 8, doi. 10.1002/pu.31159
- Publication type:
- Article
21
Atomoxetine and bupropion interaction.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 3, p. 2, doi. 10.1002/pu.31131
- By:
- Publication type:
- Article
22
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 2, p. 9, doi. 10.1002/pu.31128
- Publication type:
- Article
23
Gradual reduction of antipsychotic dosing increased relapse with no benefit in social functioning.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 4, doi. 10.1002/pu.31109
- Publication type:
- Article
24
Cholinesterase inhibitors improve psychotic symptoms in Alzheimer's and Parkinson's disease.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 12, p. 7, doi. 10.1002/pu.31099
- Publication type:
- Article
25
Staged treatment, including antidepressant, falls short for young people at risk of psychosis.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 10, p. 3, doi. 10.1002/pu.31071
- Publication type:
- Article
26
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 6, p. 9, doi. 10.1002/pu.31031
- Publication type:
- Article
27
Pimavanserin, clozapine improve symptoms of psychosis in patients with Parkinson's disease.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 6, p. 8, doi. 10.1002/pu.31028
- Publication type:
- Article
28
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 9, doi. 10.1002/pu.31006
- Publication type:
- Article
29
Haloperidol has mixed effects in ICU patients with delirium.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 1, doi. 10.1002/pu.30993
- Publication type:
- Article
30
Study suggests antipsychotics reduce work disability in first‐episode psychosis.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 2, p. 7, doi. 10.1002/pu.30975
- Publication type:
- Article
31
Discontinuing pimavanserin carries risk in treating dementia‐related psychosis.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 11, p. 1, doi. 10.1002/pu.30791
- Publication type:
- Article
32
Antipsychotic exposure leads to increase in brain volume.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 7, p. 4, doi. 10.1002/pu.30742
- Publication type:
- Article
33
An antipsychotic not marketed in U.S. led to greater improvement in trial.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 1, doi. 10.1002/pu.30688
- Publication type:
- Article
34
Sodium benzoate not effective in treatment of early psychosis.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 2, p. 8, doi. 10.1002/pu.30686
- Publication type:
- Article
35
First year critical in monitoring weight in patients on antipsychotics.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 1, p. 1, doi. 10.1002/pu.30663
- Publication type:
- Article
36
Adding second treatment improves outcome for patients with insomnia disorder.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 11, p. 1, doi. 10.1002/pu.30640
- Publication type:
- Article
37
Aripiprazole effective for patients with psychosis and hyperprolactinemia.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 10, p. 6, doi. 10.1002/pu.30631
- Publication type:
- Article
38
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 5, p. 9, doi. 10.1002/pu.30577
- Publication type:
- Article
39
MAT for alcohol improves clinical outcomes in patients with co‐occurring disorders.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 11, p. 3, doi. 10.1002/pu.30369
- Publication type:
- Article
40
Research Roundup.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 7, p. 7, doi. 10.1002/pu.30339
- Publication type:
- Article
41
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 6, p. 1, doi. 10.1002/pu.30332
- Publication type:
- Article
42
Clozapine (generic).
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 4, p. 10
- Publication type:
- Article
43
Replication trial of omega-3s shows no effect in preventing psychosis.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 3, p. 1, doi. 10.1002/pu.30211
- Publication type:
- Article
44
Effect of olanzapine on sertraline concentration.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 3, p. 2, doi. 10.1002/pu.30213
- By:
- Publication type:
- Article
45
Adjunctive taurine shows mixed results in first-episode psychosis.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 3, p. 3, doi. 10.1002/pu.30214
- Publication type:
- Article
46
Research Roundup.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 3, p. 7, doi. 10.1002/pu.30216
- Publication type:
- Article
47
Risk of extrapyramidal reactions with aripiprazole.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 1, p. 2, doi. 10.1002/pu.30197
- By:
- Publication type:
- Article
48
Youth antipsychotic treatment heightens risk of diabetes, meta-analysis finds.
- Published in:
- Brown University Psychopharmacology Update, 2016, v. 27, n. 5, p. 1, doi. 10.1002/pu.30137
- Publication type:
- Article
49
Angioedema caused by ritonavir and risperidone.
- Published in:
- Brown University Psychopharmacology Update, 2016, v. 27, n. 4, p. 2, doi. 10.1002/pu.30130
- By:
- Publication type:
- Article
50
Antipsychotic discontinuation linked to greater risk of symptom recurrence.
- Published in:
- Brown University Psychopharmacology Update, 2016, v. 27, n. 4, p. 3, doi. 10.1002/pu.30131
- Publication type:
- Article